Atypical phenylketonuria (PKU) is caused by tetrahydrobiopterin (BH4) deficiency. In Italy a systematic screening service for BH4 deficiency is not currently performed, therefore its real frequency is not known yet. We determined urinary excretion of biopterin (B) and neopterin (N) by HPLC in 74 phenylketonuric and hyperphenylalaninemic subjects, including all newborns with positive Guthrie's test for PKU since 1984. We found two patients with Nand B urinary values above the classical PKU range. In these subjects we also performed a BH410ading test that restored a normal plasma phenylalanine level in one case, while it had no effect in the other one. In both of them, the enzymatic activity of dihydropteridine reductase on dried blood spots was absent. We conclude that the determination of urinary pteridines together with the BH4 loading test are useful and informative tools in the screening of BH4 deficiencies, but that a conclusive diagnosis can only be achieved by the enzymatic assays.
Introduction
Atypical phenylketonuria (PKU) caused by tetrahydrobiopterin (BH4) deficiency was firstly described in 1974 (1) (2) (3) .
To date three different enzymatic defects have been identified as underlying the BH4 deficiency: a lack of dihydropteridine reductase (DHPR). of pyruvoyltetrahydropterin synthase (PPH 4 S) and of guanosine triphosphate cyc1ohydrolase (G TP-CH) ( 
4).
Partial, peripheral and transient reductions of PPH 4 S have also been reported, some of them still debated (5 , 6).
Since in Italy a systematic screening sen'ice for BH4 deficiency is not currently performed, its real frequency is not known yet.
We investigated 74 phenylketonuric and hyperphenylalaninemic subjects referred to our Centre for the Study and Treatment of Metabolic Diseases, including the newborns giving positive results in Guthrie's test for PKU since 1984.
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Methods
We determined urinary excretion of biopterin (B) and neopterin (N) in our 74 patients, aged between 1 month and 21 years; 45 presented classic PKU, 14 had persistent hyperphenylalaninaemia (HPA II) with relaxed phenylalanine (phe) tolerance on therapy with a low phe diet and 15 had HPA with a normal phe tolerance (plasma phe less than 10 mg/dl, on a free diet) (HPA III) (7).
As a control group, 21 age and sex matched healthy children were studied.
Urinary pteridines were assayed by high performance liquid cromatography, after acid oxidation (8).
Nand B values were analyzed in relation to creatinine (C) excretion. Table 1 sets out the means and the standard errors of the means for urinary excretion of B and the percentages of B excreted by our studied subjects. Different statistical analysis showed no correlation between plasma phe and urinary excretion in any of the groups considered and no significant correlation between the age of the subjects and their B excretion.
Results and Discussion
Comparing B excretion for each group of HPA and PKU patients with the group of healthy children, a significant difference was noted only for the PKU patients group (p < 0.01 Student's t test).
In accordance with Niederwieser (9), excretion of 13 and its percentage calculated for each subject were plotted on a system of cartesian axes (Fig. 1) .
All the controls fell within the area of normality defined by Niederwieser as follows: B/C between 0.1 and 11 mmol/mol, 100B/B+N between 10 and 81.
In the group of PKU patients, two presented B/C values of 12.5 and 11 mmol/mol and B percentage respectively of 85.2 and 82. 4. After BH410ad test (7.5 mg/kg), in one patient plasma phe level, assessed after 4 and 8 hours, fell significantly while, in the other one, it did not change.
In both these subjects, DHPR activity on dried blood spots was absent, confirming the diagnosis of DHPR deficiency (10, 11) .
The different responses to BH4 loading test point out that this approach is not resolutive for a conclusive diagnosis in patients suspected to be DHPR deficient, as many other studies previously reported.
In the group of patients with HPA III only one, clinically normal, subject had B/C and B excreted percentage values at the upper limit of normal, suggestive for a DHPR deficiency. However, the BH4 load had no effects on plasma phe level and DHPR activity on dried blood spots was normal.
In conclusion, this initial study confirms the data reported in the literature to date. In our Centre, the determination of urinary pterins pattern is systematically performed as a simple and adequately informative approach for the identification of atypical PKU forms; in our patients, we also perform a systematic determination of the DHPR activity on dried blood spots, since we are aware that a deficiency of such enzyme could be missed by urine pterins determination alone.
However we wish to emphasize the fact that a conclusive diagnosis of a deficiency of enzymes involved in the atypical forms of PKU can only be achieved by an enzyme assay.
